Westfield, NJ, United States of America

Xingfang Hong


Average Co-Inventor Count = 9.3

ph-index = 3

Forward Citations = 298(Granted Patents)


Company Filing History:


Years Active: 2002-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Xingfang Hong: A Pioneer in Pharmaceutical Patents

Introduction

Xingfang Hong is an accomplished inventor based in Westfield, NJ (US), known for his significant contributions to the field of pharmaceuticals. With a total of three patents to his name, he has made notable advancements in the development of innovative treatments for various diseases.

Latest Patents

One of his latest patents includes the development of Benzimisazo[4,5-f]isoquinolinone derivatives. These compounds serve as inhibitors of Janus protein tyrosine kinases (Jak), making them valuable as immunosuppressants and in the treatment of conditions such as asthma, allergies, and autoimmune diseases. Another significant patent involves (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents, which further showcases his expertise in creating effective pharmaceutical agents.

Career Highlights

Xingfang Hong is currently employed at Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to focus on innovative research and development, contributing to the advancement of medical science and patient care.

Collaborations

Throughout his career, Xingfang has collaborated with esteemed colleagues, including Joung L Goulet and Peter J Sinclair. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical industry.

Conclusion

Xingfang Hong's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to impact the treatment of various diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…